Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Impel Pharmaceuticals Inc (NQ: IMPL ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 15, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Impel Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > 60 Biggest Movers From Friday September 13, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... Via Benzinga Why Impel NeuroPharma Dived by 24% Today September 10, 2021 For investors, the company's price for a new share issue isn't right. Via The Motley Fool Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher September 10, 2021 Toward the end of trading Friday, the Dow traded down 0.31% to 34,772.74 while the NASDAQ fell 0.27% to 15,207.42. The S&P also fell, dropping 0.28% to 4,480.86. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Cowen Beefs Up Target Price For This Medical Device Firm September 03, 2021 Cowen has raised Impel NeuroPharma Inc's (NASDAQ: Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 10, 2021 Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC bio's stock is trading at a volume of 120.3 million... Via Benzinga Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge September 10, 2021 Midway through trading Friday, the Dow traded down 0.40% to 34,739.37 while the NASDAQ fell 0.06% to 15,238.92. The S&P also fell, dropping 0.21% to 4,483.84. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 41 Stocks Moving In Friday's Mid-Day Session September 10, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 10, 2021 Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2... Via Benzinga Impel NeuroPharma To Raise $45M Via Equity Offering September 10, 2021 Impel NeuroPharma Inc's (NASDAQ: IMPL) has priced its previously announced underwritten public offering of 3 million shares at $15.00 per share for gross... Via Benzinga 20 Stocks Moving in Friday's Pre-Market Session September 10, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2... Via Benzinga Why Impel NeuroPharma Stock Blasted 27% Higher Thursday September 09, 2021 A big sell-off in the stock is followed by a sudden bull rush, days after the company wins its first FDA approval. Via The Motley Fool Exposures Product Safety 48 Biggest Movers From Yesterday September 10, 2021 Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session September 09, 2021 Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1... Via Benzinga 30 Stocks Moving In Wednesday's Mid-Day Session September 08, 2021 Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion... Via Benzinga 54 Biggest Movers From Yesterday September 09, 2021 Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to... Via Benzinga 21 Stocks Moving in Wednesday's Pre-Market Session September 08, 2021 Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) rose 75.7% to $9.31 in pre-market trading after France's Sanofi announced plans to buy the company in a $1.9 billion deal. SPAR... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety Why Impel NeuroPharma Gained 17% Today Then Faded September 07, 2021 The FDA approval celebration is over, and the real work of selling is about to begin. Via The Motley Fool Exposures Product Safety The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week September 05, 2021 Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday... Via Benzinga 53 Biggest Movers From Friday September 07, 2021 Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera... Via Benzinga 35 Stocks Moving In Friday's Mid-Day Session September 03, 2021 Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a... Via Benzinga Why Impel NeuroPharma Stock Is Soaring Today September 03, 2021 The company's nasal spray got a green light from the FDA to treat migraine headaches. Via The Motley Fool Exposures Product Safety Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August September 03, 2021 Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66. The U.S.... Via Benzinga Topics Economy Stocks Exposures Economy US Equities FDA Gives Nod To Nasal Spray Migraine Treatment From Impel NeuroPharma; Stock Jumps September 03, 2021 The FDA has approved Impel NeuroPharma Inc's (NASDAQ: IMPL) Trudhesa (dihydroergotamine mesylate) nasal spray for the acute treatment of migraine with or... Via Benzinga Exposures Product Safety Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates August 31, 2021 August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New... Via Benzinga 38 Stocks Moving In Friday's Mid-Day Session August 20, 2021 Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares climbed 45.8% to $6.27 after the company presented data from ongoing studies of its preventive vaccine against COVID-19, showing... Via Benzinga Exposures COVID-19 38 Stocks Moving In Thursday's Mid-Day Session August 19, 2021 Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial... Via Benzinga The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 58 Biggest Movers From Yesterday August 20, 2021 Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... Via Benzinga 46 Biggest Movers From Yesterday August 19, 2021 Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.